US Broker Ratings

Encompass Health Corporation (EHC)

⚠️ No article content returned.

..

Pfizer Inc. (PFE) Stock Analysis: Navigating Opportunities Amid a 6.36% Dividend Yield

Pfizer Inc. (NYSE: PFE), the New York-based pharmaceutical giant, commands a prominent position in the healthcare sector with a market capitalization of $153.81 billion. Despite the..

West Pharmaceutical Services, Inc. (WST) Stock Analysis: Unlocking a Potential 29.49% Upside

West Pharmaceutical Services, Inc. (NYSE: WST), a key player in the healthcare sector, particularly within the medical instruments and supplies industry, presents a compelling investment opportunity..

Henry Schein, Inc. (HSIC) Investor Outlook: Explore a 15.7% Upside Potential

Henry Schein, Inc. (NASDAQ: HSIC), a titan in the healthcare sector specializing in medical distribution, stands out with a notable market capitalization of $9.14 billion. Despite..

GSK plc (GSK) Stock Analysis: Exploring a 5.44% Potential Upside in the Healthcare Sector

GSK plc (NYSE: GSK), a titan in the healthcare sector, continues to be a focal point for investors due to its robust product pipeline and global..

Natera, Inc. (NTRA) Stock Analysis: Why this Diagnostics Leader Offers a Potential 31.56% Upside

Natera, Inc. (NASDAQ: NTRA) stands out in the healthcare sector as a robust player in the diagnostics and research industry. With a market capitalization of $28.08..

Genmab A/S (GMAB) Stock Analysis: Exploring a 39% Potential Upside for Biotechnology Investors

As a pioneering force in the biotechnology sector, Genmab A/S (GMAB) stands out not only for its innovative antibody-based therapies but also for its compelling investment..

Corcept Therapeutics (CORT) Investor Outlook: Unpacking the 93% Potential Upside

Corcept Therapeutics Incorporated (CORT), a biopharmaceutical company based in Redwood City, California, is capturing investor attention with a compelling story of innovation and potential growth within..

McKesson Corporation (MCK) Stock Analysis: Healthcare Giant with a Robust Growth Trajectory

As one of the stalwarts in the healthcare sector, McKesson Corporation (NYSE: MCK) continues to stand out in the medical distribution industry. With a market capitalization..

Neurocrine Biosciences, Inc. (NBIX) Investor Outlook: Exploring a 38% Potential Upside Amid Strong Revenue Growth

Neurocrine Biosciences, Inc. (NASDAQ: NBIX), a prominent player in the healthcare sector, continues to draw investor attention with its compelling financial metrics and robust product pipeline...

Globus Medical, Inc. (GMED) Stock Analysis: Exploring a 25.76% Potential Upside

Globus Medical, Inc. (NYSE: GMED), a leading player in the healthcare sector, particularly within the medical devices industry, continues to capture investor attention with its innovative..

Amgen Inc. (AMGN) Stock Analysis: Evaluating a Solid Player in the Healthcare Sector with Robust Dividend Yield

Amgen Inc. (NASDAQ: AMGN), a stalwart in the healthcare sector, has long been a reliable choice for investors seeking exposure to the pharmaceutical industry. With a..

Becton, Dickinson and Company (BDX) Stock Analysis: A 17.97% Potential Upside Beckons Investors

Becton, Dickinson and Company (NYSE: BDX), a venerable player in the healthcare sector, is garnering attention from investors thanks to its robust market presence and a..

Tempus AI, Inc. (TEM) Investor Outlook: Exploring a 48% Potential Upside in Healthcare Tech

Tempus AI, Inc. (NASDAQ: TEM) has emerged as a significant player in the healthcare technology sector, operating at the intersection of artificial intelligence and healthcare services...

Charles River Laboratories Inte (CRL) Stock Analysis: Navigating Potential 13% Upside with Strong Buy Ratings

Charles River Laboratories International, Inc. (NYSE: CRL) stands as a prominent player in the healthcare sector, specifically within the diagnostics and research industry. With a market..

Exelixis, Inc. (EXEL) Stock Analysis: Exploring a 12.73% Upside Potential in the Biotech Sector

Exelixis, Inc. (NASDAQ: EXEL), a key player in the biotechnology sector, presents an intriguing opportunity for investors seeking exposure to the healthcare industry. With a market..

Labcorp Holdings Inc. (LH) Stock Analysis: A Diagnostic Leader with a 14% Upside Potential

Labcorp Holdings Inc. (NYSE: LH), a prominent player in the healthcare sector, particularly in diagnostics and research, stands out with a market capitalization of $22.36 billion...

Universal Health Services, Inc. (UHS) Stock Analysis: Exploring a 30% Upside Potential

Universal Health Services, Inc. (NYSE: UHS), a prominent player in the healthcare sector, is gaining attention from investors due to its strong growth metrics and potential..

argenx SE (ARGX) Stock Analysis: A Biotech Powerhouse with a 41% Potential Upside

argenx SE (NASDAQ: ARGX) stands as a formidable entity within the biotechnology sector, capturing the interest of investors with its innovative approach to treating autoimmune diseases...

The Ensign Group, Inc. (ENSG) Stock Analysis: Strong Revenue Growth and a 6.36% Upside Potential

For investors seeking opportunities in the healthcare sector, The Ensign Group, Inc. (NASDAQ: ENSG) offers a compelling prospect. With a market capitalization of $12.04 billion, Ensign..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds